These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37899914)

  • 1. Economic Burden of Vision Loss and Eye Disorders in Iran.
    Rezapour A; Adel A; Aboutorabi A; Askarzade E; Barghazan SH; Pourtaleb A; Tabatabaee SS
    Iran J Public Health; 2023 Oct; 52(10):2207-2215. PubMed ID: 37899914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of major depressive disorder: a case study in Southern Iran.
    Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
    BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UK.
    Lafuma A; Brézin A; Lopatriello S; Hieke K; Hutchinson J; Mimaud V; Berdeaux G
    Pharmacoeconomics; 2006; 24(2):193-205. PubMed ID: 16460138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect medical costs of bladder cancer in Iran.
    Raadabadi M; Daroudi R; Zendehdel K; Haghdoost AA; Ebadzadeh MR; Rashidian H
    Cost Eff Resour Alloc; 2023 Jan; 21(1):5. PubMed ID: 36647054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of bipolar disorder: a case study in Southern Iran.
    Shaker Z; Goudarzi Z; Ravangard R; Shaker Z; Hedayati A; Keshavarz K
    Cost Eff Resour Alloc; 2024 Jul; 22(1):55. PubMed ID: 39026286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of visual impairment associated with eye diseases: exploratory survey of 298 Chinese patients.
    Guan X; Fu M; Lin F; Zhu D; Vuillermin D; Shi L
    BMJ Open; 2019 Sep; 9(9):e030561. PubMed ID: 31515429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of breast cancer: a case of Southern Iran.
    Jalali FS; Keshavarz K; Seif M; Akrami M; Jafari A; Ravangard R
    Cost Eff Resour Alloc; 2023 Aug; 21(1):58. PubMed ID: 37644546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Epidermolysis Bullosa Disease in Iran.
    Forghani SF; Jahangiri R; Ghasemi F; Shirani R; Bagheri H; Mahmoodi R; Bagheri Faradonbeh S
    Med J Islam Repub Iran; 2021; 35():146. PubMed ID: 35321378
    [No Abstract]   [Full Text] [Related]  

  • 10. Costs of interventions for visual impairment.
    Taylor HR; Pezzullo ML; Nesbitt SJ; Keeffe JE
    Am J Ophthalmol; 2007 Apr; 143(4):561-5. PubMed ID: 17222383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of hepatitis B virus-related diseases: evidence from iran.
    Keshavarz K; Kebriaeezadeh A; Alavian SM; Akbari Sari A; Abedin Dorkoosh F; Keshvari M; Malekhosseini SA; Nikeghbalian S; Nikfar S
    Hepat Mon; 2015 Apr; 15(4):e25854. PubMed ID: 25977694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of esophageal cancer in Iran.
    Daroudi R; Nahvijou A; Arab M; Faramarzi A; Kalaghchi B; Sari AA
    Indian J Cancer; 2022; 59(4):499-506. PubMed ID: 34380822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden of Gastric Cancer: A Case of Iran.
    Eghdami A; Ostovar R; Jafari A; Palmer AJ; Bordbar N; Ravangard R
    Cancer Control; 2019; 26(1):1073274819837185. PubMed ID: 30924358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.
    Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of cardiovascular diseases before and after Iran's health transformation plan: evidence from a referral hospital of Iran.
    Alipour V; Zandian H; Yazdi-Feyzabadi V; Avesta L; Moghadam TZ
    Cost Eff Resour Alloc; 2021 Jan; 19(1):1. PubMed ID: 33390167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of osteoporosis in Iran in 2020.
    Ostovar A; Mousavi A; Sajjadi-Jazi SM; Rajabi M; Larijani B; Fahimfar N; Daroudi R
    Osteoporos Int; 2022 Nov; 33(11):2337-2346. PubMed ID: 35821307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.